Ignite Creation Date:
2024-05-06 @ 8:21 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06355466
Status:
COMPLETED
Last Update Posted:
2024-04-09
First Post:
2023-12-23
Brief Title:
Tunneled Hemodialysis Catheters as Permanent Vascular Access Evaluating One-year Patency Rate and Affecting Factors
Sponsor:
Golestan University of Medical sciences
Organization:
Golestan University of Medical sciences
Study Overview
Official Title:
Evaluation of Duration of the Long-term Hemodialysis Catheters Patency and Its Effecting Factors in Chronic Hemodialysis Patients in Golestan Province in 1400-1401
Status:
COMPLETED
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In this prospective cross-sectional study patients with ESRD unfit for AVFAVG were scheduled for a right or left trans-jugular tunneled catheter placement All patients were asked about their catheters function one year after its implantation and the presumed affecting factors on catheters patency were evaluated
Detailed Description:
In this prospective cross-sectional study the population consisted of patients with end-stage renal failure who were undergoing chronic hemodialysis from 2021-2022 in Golestan province Patients with end-stage renal failure who were candidates to start or continue dialysis through tunneled catheters as permanent access were included in the study
According to the 2019 KDOQI guideline all of the patients were excluded from AVF AVG implantation because of one or more of these reasons heart failure failed AVFAVG with no remaining viable option for new AVFAVG construction absence of suitable artery vein for AVF or AVG construction patients preference despite understanding the superiority of AVFAVG to catheters
Written informed consent was obtained from all of the patients for conduction and publication of the study
In all patients the priority was to insert the catheter through the right jugular unless their right jugular vein was occluded in the preoperative ultrasound or if it was not possible to pass the wire through the right jugular vein to the right atrium In these patients the left jugular vein was used as the insertion site In some patients left side catheter insertion was not possible as well These patients whose catheters were placed somewhere else were excluded from the study In all cases the proper location of the catheter tip -at the junction of the superior vena cava with the right atrium- was ensured using intraoperative fluoroscopy with a C-arm For this purpose catheters of a tip-to-cuff size of 19 and 23 were installed on the right and left side respectively For at least one post-implantation session proper hemodialysis function of the catheter was ensured All patients underwent surgery by the same vascular surgeon in a single secondaryteaching public center and due to the restrictions rendered by economic sanctions a single brand of catheter was used for all patients A special questionnaire was utilized to record data on age gender underlying diseases diabetes or high blood pressure medications and catheter location All patients catheter efficacy was re-evaluated one year later by referring to their hemodialysis center or by calling them and the adequacy of their catheters was recorded to provide adequate flow for hemodialysis The affecting factors on catheters patency were evaluated and analysed using statistical software
According to the 2019 KDOQI guideline all of the patients were excluded from AVF AVG implantation because of one or more of these reasons heart failure failed AVFAVG with no remaining viable option for new AVFAVG construction absence of suitable artery vein for AVF or AVG construction patients preference despite understanding the superiority of AVFAVG to catheters
Written informed consent was obtained from all of the patients for conduction and publication of the study
In all patients the priority was to insert the catheter through the right jugular unless their right jugular vein was occluded in the preoperative ultrasound or if it was not possible to pass the wire through the right jugular vein to the right atrium In these patients the left jugular vein was used as the insertion site In some patients left side catheter insertion was not possible as well These patients whose catheters were placed somewhere else were excluded from the study In all cases the proper location of the catheter tip -at the junction of the superior vena cava with the right atrium- was ensured using intraoperative fluoroscopy with a C-arm For this purpose catheters of a tip-to-cuff size of 19 and 23 were installed on the right and left side respectively For at least one post-implantation session proper hemodialysis function of the catheter was ensured All patients underwent surgery by the same vascular surgeon in a single secondaryteaching public center and due to the restrictions rendered by economic sanctions a single brand of catheter was used for all patients A special questionnaire was utilized to record data on age gender underlying diseases diabetes or high blood pressure medications and catheter location All patients catheter efficacy was re-evaluated one year later by referring to their hemodialysis center or by calling them and the adequacy of their catheters was recorded to provide adequate flow for hemodialysis The affecting factors on catheters patency were evaluated and analysed using statistical software
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None